Deccan Health Care Limited reported a standalone net profit of ₹24.63 lakh for the quarter ended June 30, 2026, marking a 15.9% increase from ₹21.25 lakh in the corresponding period of FY26. The Hyderabad-based nutraceutical manufacturer saw its revenue from operations rise 1.8% year-on-year to ₹2,185.61 lakh, compared to ₹2,146.95 lakh in Q1FY26.

On a consolidated basis, which includes subsidiary Beyoungstore Private Limited, net profit climbed 22.8% to ₹29.11 lakh from ₹23.71 lakh a year ago. Consolidated revenue from operations remained relatively flat at ₹2,206.91 lakh, down marginally from ₹2,214.02 lakh in the prior-year quarter.

The Board of Directors approved the unaudited financial results during a meeting held on August 14, 2026. The results were reviewed by statutory auditors Keyur Shah & Associates pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Standalone Financial Performance

Revenue growth was modest but accompanied by an improvement in profitability metrics. Earnings per share (basic and diluted) stood at ₹0.10, up from ₹0.09 in Q1FY26.

Cost of materials consumed rose to ₹2,247.34 lakh from ₹1,905.21 lakh in the previous year’s quarter. However, this was partially offset by a significant decrease in inventory values, recorded as negative changes of ₹745.48 lakh, compared to ₹361.27 lakh in Q1FY26. Employee benefit expenses declined slightly to ₹120.64 lakh from ₹136.37 lakh.

What the Numbers Show

The divergence between rising material costs and stable revenue highlights the impact of inventory adjustments on the bottom line. While cost of materials consumed increased by approximately 18% year-on-year, the company benefited from a larger reduction in finished goods and work-in-progress inventory (₹745.48 lakh vs ₹361.27 lakh). This inventory drawdown effectively lowered total expenses relative to revenue, supporting the expansion in net profit despite modest top-line growth.

Consolidated Results

The consolidated figures reflect the inclusion of Beyoungstore Private Limited, which contributed ₹259.44 lakh to total income and ₹4.50 lakh to profit after tax for the quarter.

Consolidated earnings per share were ₹0.12, compared to ₹0.10 in the same quarter last year. Other comprehensive income showed a minor loss of ₹0.28 lakh for both standalone and consolidated entities, consistent with the prior year’s pattern.

The company reported no investor complaints pending or received during the quarter. Paid-up equity share capital remained unchanged at ₹2,474.92 lakh.

Deccan Health Care Limited shareholders approved the regularization of three independent directors on July 24, 2026, reinforcing its corporate governance structure. The first Extraordinary General Meeting (EGM), held via Video Conferencing and Other Audio Visual Means (OAVM) from its Hyderabad registered office, saw special resolutions pass with overwhelming support. The appointments of Bhupendra Singh Kataria, Pratiksha Bisht, and Manju Singh as Non-Executive Independent Directors were ratified, ensuring compliance with regulatory norms for board composition.

The resolutions received 99.96% affirmative votes, reflecting strong alignment between promoters and public shareholders. Promoter group members, holding 45,58,738 shares, voted unanimously in favor. Public non-institutional shareholders, holding 1,75,37,025 shares, also supported the moves, with only 2,400 votes cast against each resolution. No institutional public shareholders participated in the voting process. The high approval rate underscores shareholder confidence in the proposed board changes.

Voting Breakdown

The voting results, scrutinized by Monika Bhatia of M/S M. R. Bhatia & Co., were submitted to BSE Limited pursuant to Regulation 44(3) of the SEBI Listing Regulations. The remote e-voting window operated from July 21 to July 23, 2026, with additional voting permitted during the EGM session. A total of 68,36,571 votes were polled out of 2,34,25,513 shares held by eligible shareholders as of the record date, July 17, 2026.

Procedural Compliance

Minto Purshottam Gupta, Managing Director and Chairman, presided over the meeting, which commenced at 3:00 P.M. and concluded at 3:25 P.M. Twenty-six shareholders attended virtually, comprising two promoter representatives and twenty-four public shareholders. Shikha Das, Company Secretary and Compliance Officer, was authorized to declare the results. The proceedings adhered to Section 108 of the Companies Act, 2013, and relevant SEBI Listing Regulations. The Scrutinizer’s report confirmed that no invalid votes were recorded, and all electronic data remains secure until the minutes are finalized.